Publicacións en colaboración con investigadores/as de Imperial College London (11)

2024

  1. Clinical-Hematological Changes and Predictors of Severity in Acute Food Protein–Induced Enterocolitis Syndrome Reactions at Oral Food Challenge: A Multicenter Observational Study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 9, pp. 2454-2467.e8

  2. Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision

    The British journal of surgery, Vol. 111, Núm. 5

  3. Whole Exome Sequencing Identifies Epithelial and Immune Dysfunction-Related Biomarkers in Food Protein-Induced Enterocolitis Syndrome

    Clinical and Experimental Allergy

2023

  1. A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis

    Frontiers in Immunology, Vol. 14

  2. Infected pancreatic necrosis: outcomes and clinical predictors of mortality. A post hoc analysis of the MANCTRA-1 international study

    Updates in Surgery, Vol. 75, Núm. 3, pp. 493-522

2021

  1. Children with acute food protein-induced enterocolitis syndrome from Spain and Italy usually tolerate all other food groups

    Clinical and Experimental Allergy

  2. Impact of COVID-19 on vascular patients worldwide: Analysis of the COVIDSurg data

    Journal of Cardiovascular Surgery, Vol. 62, Núm. 6, pp. 558-570

  3. Long-term Evaluation of Fistulotomy and Immediate Sphincteroplasty as a Treatment for Complex Anal Fistula

    Diseases of the Colon and Rectum, Vol. 64, Núm. 11, pp. 1374-1384

2019

  1. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180

2018

  1. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

    Clinical and Translational Allergy, Vol. 8, Núm. 1

2017

  1. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

    New England Journal of Medicine, Vol. 377, Núm. 13, pp. 1228-1239